$8.66
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 55 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Country

US

CEO

Mr. Morgan Frank

IPO date

2008

Employees

55

ISIN

US80303D3052

Key stats

Open

$8.80

Volume

1.04M

Market cap

$73.18M

Prev. close

$8.51

Impl / hst vl

-

Open interest

$0.00

$8.34

Day’s Range

$9.19

$8.30

52W Range

$32.87

Valuation

44
Valuation score
Fairly Valued
P/E
9.26
P/S
3.35
P/B
80.85
Current ratio
1.31
Debt / Equity
5.33
ROE
270.18%
Gross margin
77.25%
Income growth
-123.56%
FCF growth
-92.58

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$44.37
The top 4 analysts forecasts that 12-month price may increase by 412.36%, with a low of $40.40 and a high of $49.35
$40.40
Low
$44.37
Avg
$49.35
High
Current price

Earnings

Q1 ‘26 revenue
$9.62M
Q1 ‘26 net income
-$1.44M
Revenue
Net income
Previous EPS
$0.89
Estimate EPS
-$0.05
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply